InvestorsHub Logo
Followers 62
Posts 7555
Boards Moderated 1
Alias Born 01/02/2003

Re: AJLite post# 405788

Wednesday, 03/15/2023 9:52:14 AM

Wednesday, March 15, 2023 9:52:14 AM

Post# of 426447
AJ...QUOTE..."Indeed, why has it taken so long to develop since 2013?"...

In 2013, the FDA had rejected the CVD indication for Vascepa and Amarin was facing a long and an expensive R-IT study...They had to mortgage their patents to borrow enough money for the study...They were not in the position they are now in.... with FDA approval of Vascepa for CVD and 300 million in cash plus no debt.

I agree that, in retrospect, after the judge Du decision, Amarin should have immediately initiated work on a FDC.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News